The Found Script
Go beyond finding medications. Expert guides, shortage updates, and tips for navigating the healthcare system.
Browse all articles A–Z →
Dasatinib Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing for hematologists and oncologists on dasatinib access in 2026—specialty pharmacy navigation, prior auth, generics, and patient assistance options.

Celestone Soluspan Shortage: What Providers and Prescribers Need to Know in 2026
Celestone Soluspan supply disruptions are affecting clinics and practices in 2026. A clinical briefing for providers: substitution options, dosing equivalencies, and patient guidance.

D-Penamine Shortage: What Providers and Prescribers Need to Know in 2026
A provider-focused briefing on D-Penamine (Penicillamine) availability, prescribing implications, alternatives, and tools to help patients in 2026.

Dabigatran Etexilate Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing for providers on Dabigatran Etexilate supply in 2026, including availability, prescribing considerations, and patient tools.
48,000+ have already found their meds with Medfinder.
Stop calling pharmacies. Start your search today.

Dabigatran Etexilate Shortage: What Providers and Prescribers Need to Know in 2026
A provider-focused briefing on Dabigatran Etexilate availability in 2026, including prescribing implications, alternatives, cost data, and patient tools.

Buspirone Shortage: What Providers and Prescribers Need to Know in 2026
A provider-focused update on Buspirone availability in 2026 — shortage timeline, prescribing implications, alternatives, cost data, and tools to help patients.

Aurovela Fe 24 1/20 28 Day Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing on the Aurovela Fe 24 1/20 shortage for providers: supply timeline, prescribing implications, alternatives, and patient tools.

Balmex Ointment Shortage: What Providers and Prescribers Need to Know in 2026
A provider briefing on Balmex Ointment availability in 2026, including supply status, alternatives, cost data, and patient communication tools.

Afrezza Shortage: What Providers and Prescribers Need to Know in 2026
A provider's briefing on Afrezza availability in 2026. Current supply status, prescribing implications, insurance landscape, and tools to help your patients access inhaled insulin.

Abrilada Shortage: What Providers and Prescribers Need to Know in 2026
A provider briefing on Abrilada availability in 2026. Learn about prescribing implications, the biosimilar landscape, and tools to help patients access treatment.

How to Help Your Patients Save Money on Valium: A Provider's Guide to Savings Programs
A provider's guide to helping patients afford Valium (diazepam): discount programs, formulary strategies, patient assistance resources, and cost-saving prescribing tips.

Entyvio Shortage: What Providers and Prescribers Need to Know in 2026
A provider briefing on Entyvio (Vedolizumab) supply in 2026. Coverage of availability, prescribing considerations, cost, and patient access tools.